Bella Vista. ResMed speaks on R & D tax

Medical devices company, ResMed Limited, at Bella Vista, has spoken out against the rumoured cuts to the R & D tax incentive. ResMed CFO, Brett Sandercock, told media that it had factored in the tax incentive when it built its R&D department. If the incentive is cut, it will incur increased costs if it continues to develop its products in Australia. ResMed is heavily R&D-focused, as are other medical devices and pharmaceutical companies in Australia.